Showing results (41-50 of 109) with videos related to
Sort By:
Pageof 11
Cancers|December 11, 2022
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with ImmunotherapyAndrea De Giglio, Elisa Tassinari, Arianna Zappi, et al.Anti-Cancer Drugs|August 18, 2021
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinomaGiovanni Brandi, Alessandro Di Federico, Alessandro Rizzo, et al.Research Square|February 5, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersRoberto Chiarle, Taek-Chin Cheong, Ahram Jang, et al.Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Hacking Pancreatic Cancer: Present and Future of Personalized MedicineAlessandro Di Federico, Valentina Tateo, Claudia Parisi, et al.Current Oncology Reports|June 28, 2023
Resistance to KRAS G12C Inhibition in Non-small Cell Lung CancerAlessandro Di Federico, Ilaria Ricciotti, Valentina Favorito, et al.Cancers|May 28, 2022
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment OutcomesAlessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.Current Oncology (Toronto, Ont.)|May 26, 2023
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of CholangiocarcinomaAndrea Palloni, Silvia Bisello, Ilaria Maggio, et al.Lung Cancer (Amsterdam, Netherlands)|September 15, 2020
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients - A single centre experienceFilippo G Dall'Olio, Nicole Conci, Giulio Rossi, et al.Translational Lung Cancer Research|September 12, 2022
Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysisDongliang Bian, Siming Jiang, Yicheng Xiong, et al.Nature Communications|June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersTaek-Chin Cheong, Ahram Jang, Qi Wang, et al.Pageof 11